Skip to main content

Chronic Stable Angina

6
Pipeline Programs
6
Companies
6
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
3
0
1
0
0
2
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

6 companies ranked by most advanced pipeline stage

Kite Pharma
Kite PharmaCA - El Segundo
2 programs
2
RanolazinePhase 4
ranolazinePhase 4
Bayer
BayerLEVERKUSEN, Germany
1 program
1
CapadenosonPhase 21 trial
Active Trials
NCT00518921Withdrawn0Est. Nov 2008
Chong Kun Dang Pharmaceutical
2 programs
2
Dilatrend 64mg capsulePhase 11 trial
Dilatrend SR capsulePhase 11 trial
Active Trials
NCT01340248Completed24Est. Aug 2011
NCT01369472Completed30Est. Oct 2011
Auxilius Pharma
Auxilius PharmaNY - Brooklyn
1 program
1
AUX-001Phase 11 trial
Active Trials
NCT06249581Unknown16Est. Feb 2024
Gilead Sciences
Gilead SciencesFOSTER CITY, CA
2 programs
ranolazinePHASE_41 trial
ranolazinePHASE_4
Active Trials
NCT01558830Unknown50Est. Jul 2013
Biosensors International
Biosensors InternationalSingapore - Singapore
1 program
Biolimus-eluting stent implantationN/A1 trial
Active Trials
NCT01760083Completed450Est. Nov 2018

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Gilead Sciencesranolazine
BayerCapadenoson
Auxilius PharmaAUX-001
Chong Kun Dang PharmaceuticalDilatrend 64mg capsule
Chong Kun Dang PharmaceuticalDilatrend SR capsule
Biosensors InternationalBiolimus-eluting stent implantation

Clinical Trials (6)

Total enrollment: 570 patients across 6 trials

Safety of Amiodarone and Ranolazine Together in Patients With Angina

Start: Jan 2012Est. completion: Jul 201350 patients
Phase 4Unknown
NCT00518921BayerCapadenoson

Capadenoson in Angina Pectoris

Start: Mar 2008Est. completion: Nov 20080
Phase 2Withdrawn

Pharmacokinetics of AUX-001 40mg Once-daily in Healthy Subjects Under Fasting and Fed Conditions

Start: Nov 2023Est. completion: Feb 202416 patients
Phase 1Unknown

A Randomized, Open-label, Single-dose, Crossover Clinical Trial to Evaluate the Food Effect on the Pharmacokinetics of Dilatrend SR 64mg Capsule After Oral Administration in Healthy Male Volunteers

Start: Jul 2011Est. completion: Aug 201124 patients
Phase 1Completed

Evaluating Dose-proportionality of Dilatrend Suspended-Release Capsule

Start: Jun 2011Est. completion: Oct 201130 patients
Phase 1Completed
NCT01760083Biosensors InternationalBiolimus-eluting stent implantation

A Randomized Multicentre Trial to Evaluate the Utilization of Revascularization or Optimal Medical Therapy for the Treatment of Chronic Total Coronary Occlusions

Start: Jan 2013Est. completion: Nov 2018450 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

6 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.